微粒体
细胞色素P450
辅因子
烟酰胺腺嘌呤二核苷酸磷酸
新陈代谢
酶
代谢稳定性
药物代谢
生物化学
药品
细胞色素
代谢途径
化学
药理学
生物
体外
氧化酶试验
作者
Matthew L. Landry,Richard Trager,Fabio Broccatelli,James J. Crawford
标识
DOI:10.1021/acsmedchemlett.2c00071
摘要
The metabolic stability of compounds is often assessed at an early stage in drug discovery programs by profiling with hepatic microsomes. Exclusion of the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) in these assays provides insight into non-cytochrome P450 (CYP)-mediated metabolism. This report uses a matched molecular pair (MMP) application to assess which chemical substituents are commonly susceptible to non-NADPH-mediated metabolism by microsomes. The analysis found the overall prevalence of metabolism in the absence of NADPH to be low, with esters, amides, aldehydes, and oxetanes being among the most commonly susceptible functional groups. Given that non-CYP enzymes, such as esterases, may be expressed extrahepatically and lead to lower confidence in predicted pharmacokinetic profiles, an awareness of the functional groups that commonly undergo non-NADPH-mediated metabolism-as well as options for their replacement based on experimental MMP data-may help researchers derisk metabolic stability issues at an earlier stage in drug discovery.
科研通智能强力驱动
Strongly Powered by AbleSci AI